These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22583555)

  • 1. Serum metabolomic profile as a means to distinguish stage of colorectal cancer.
    Farshidfar F; Weljie AM; Kopciuk K; Buie WD; Maclean A; Dixon E; Sutherland FR; Molckovsky A; Vogel HJ; Bathe OF
    Genome Med; 2012 May; 4(5):42. PubMed ID: 22583555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.
    Wang Z; Lin Y; Liang J; Huang Y; Ma C; Liu X; Yang J
    Oncotarget; 2017 Dec; 8(62):105819-105831. PubMed ID: 29285295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 5. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
    Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
    Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
    Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
    Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
    J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of identifying pancreatic cancer based on serum metabolomics.
    Bathe OF; Shaykhutdinov R; Kopciuk K; Weljie AM; McKay A; Sutherland FR; Dixon E; Dunse N; Sotiropoulos D; Vogel HJ
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):140-7. PubMed ID: 21098649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
    Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing metabolic changes in human colorectal cancer.
    Williams MD; Zhang X; Park JJ; Siems WF; Gang DR; Resar LM; Reeves R; Hill HH
    Anal Bioanal Chem; 2015 Jun; 407(16):4581-95. PubMed ID: 25943258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of gas chromatograph/mass spectrometry-based serum metabolic profiling of colorectal cancer after operation.
    Ma Y; Liu W; Peng J; Huang L; Zhang P; Zhao X; Cheng Y; Qin H
    Mol Biol Rep; 2010 Mar; 37(3):1403-11. PubMed ID: 19340605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
    Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
    BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
    Li Y; Wang C; Li D; Deng P; Shao X; Hu J; Liu C; Jie H; Lin Y; Li Z; Qian X; Zhang H; Zhao Y
    Oncol Rep; 2017 Nov; 38(5):3044-3054. PubMed ID: 28901465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and metabolomic characterization of Brivanib-Induced hypertension in metastatic colorectal cancer.
    Rattner JI; Kopciuk KA; Vogel HJ; Tang PA; Shapiro JD; Tu D; Jonker DJ; Siu LL; O'Callaghan CJ; Bathe OF
    Cancer Med; 2023 Aug; 12(15):16019-16031. PubMed ID: 37329221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue metabolic profiling of lymph node metastasis of colorectal cancer assessed by 1H NMR.
    Zhang H; Qiao L; Li X; Wan Y; Yang L; Wang H
    Oncol Rep; 2016 Dec; 36(6):3436-3448. PubMed ID: 27748865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
    Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment.
    Hao D; Sarfaraz MO; Farshidfar F; Bebb DG; Lee CY; Card CM; David M; Weljie AM
    Metabolomics; 2016; 12():58. PubMed ID: 27073350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.
    Kosmopoulou M; Giannopoulou AF; Iliou A; Benaki D; Panagiotakis A; Velentzas AD; Konstantakou EG; Papassideri IS; Mikros E; Stravopodis DJ; Gikas E
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244549
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.